pI: 6.6382 |
Length (AA): 93 |
MW (Da): 10737 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128224)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G30330 | small nuclear ribonucleoprotein E |
Babesia bovis | BBOV_IV002640 | small nuclear ribonucleoprotein E, putative |
Brugia malayi | Bm1_16025 | small nuclear ribonucleoprotein E |
Caenorhabditis elegans | CELE_Y49E10.15 | Protein SNR-6 |
Cryptosporidium parvum | cgd4_1660 | small nuclear ribonucleoprotein, putative |
Dictyostelium discoideum | DDB_G0302414 | small nuclear ribonucleoprotein E |
Drosophila melanogaster | Dmel_CG18591 | Small ribonucleoprotein particle protein SmE |
Echinococcus granulosus | EgrG_000181000 | small nuclear ribonucleoprotein polypeptide |
Entamoeba histolytica | EHI_141910 | LSM domain containing protein |
Echinococcus multilocularis | EmuJ_000181000 | small nuclear ribonucleoprotein polypeptide |
Homo sapiens | 6635 | small nuclear ribonucleoprotein polypeptide E |
Leishmania braziliensis | LbrM.30.1330 | small nuclear ribonucleoprotein polypeptide e, putative |
Leishmania donovani | LdBPK_301270.1 | small nuclear ribonucleoprotein polypeptide e, putative |
Leishmania infantum | LinJ.30.1270 | small nuclear ribonucleoprotein polypeptide e, putative |
Leishmania major | LmjF.30.1205 | small nuclear ribonucleoprotein polypeptide e, putative |
Leishmania mexicana | LmxM.29.1205 | small nuclear ribonucleoprotein polypeptide e, putative |
Loa Loa (eye worm) | LOAG_06135 | small nuclear ribonucleoprotein E |
Mus musculus | 102632439 | predicted gene 14284 |
Mus musculus | ENSMUSG00000090553 | small nuclear ribonucleoprotein E |
Neospora caninum | NCLIV_007180 | hypothetical protein |
Oryza sativa | 4328158 | Os02g0126700 |
Plasmodium berghei | PBANKA_1363000 | small nuclear ribonucleoprotein E, putative |
Plasmodium falciparum | PF3D7_1350200 | small nuclear ribonucleoprotein E, putative |
Plasmodium knowlesi | PKNH_1250700 | small nuclear ribonucleoprotein E, putative |
Plasmodium vivax | PVX_083405 | small nuclear ribonucleoprotein E, putative |
Plasmodium yoelii | PY05604 | small nuclear ribonucleoprotein homolog |
Saccharomyces cerevisiae | YOR159C | Sme1p |
Schistosoma japonicum | Sjp_0103260 | Small nuclear ribonucleoprotein E, putative |
Trypanosoma brucei gambiense | Tbg972.6.2470 | small nuclear ribonucleoprotein Sm-E |
Trypanosoma brucei | Tb927.6.2700 | small nuclear ribonucleoprotein Sm-E |
Trypanosoma cruzi | TcCLB.511499.59 | small nuclear ribonucleoprotein Sm-E, putative |
Trypanosoma cruzi | TcCLB.509965.30 | small nuclear ribonucleoprotein Sm-E, putative |
Toxoplasma gondii | TGME49_275750 | small nuclear ribonucleoprotein E, putative |
Theileria parva | TP03_0386 | small nuclear ribonucleoprotein, putative |
Trichomonas vaginalis | TVAG_473940 | Small nuclear ribonucleoprotein E, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.2700 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.2700 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.2700 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.2700 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y49E10.15 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_Y49E10.15 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y49E10.15 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y49E10.15 | Caenorhabditis elegans | slow growth | wormbase |
CELE_Y49E10.15 | Caenorhabditis elegans | sterile | wormbase |
YOR159C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_275750 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.